{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T05:55:24Z","timestamp":1771480524024,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":2369,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","fertstert.org","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.fertnstert.2015.08.014","type":"journal-article","created":{"date-parts":[[2015,9,8]],"date-time":"2015-09-08T08:07:24Z","timestamp":1441699644000},"page":"1419-1425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["450 IU versus 600 IU gonadotropin for controlled ovarian stimulation in poor responders: a randomized controlled trial"],"prefix":"10.1016","volume":"104","clinical-trial-number":[{"clinical-trial-number":"nct00971152","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Jessica","family":"Lefebvre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Antaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isaac-Jacques","family":"Kadoch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola L.","family":"Dean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camille","family":"Sylvestre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Bissonnette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne","family":"Benoit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvain","family":"M\u00e9nard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Lapens\u00e9e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2015.08.014_bib1","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1471-0528.1997.tb11525.x","article-title":"Assisted conception following poor ovarian response to gonadotrophin stimulation","volume":"104","author":"Keay","year":"1997","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2015.08.014_bib2","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1093\/humrep\/14.7.1744","article-title":"A rational approach to the management of low responders in in-vitro fertilization","volume":"14","author":"Karande","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2015.08.014_bib3","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/oxfordjournals.humrep.a137459","article-title":"Comparison of \u201cpoor\u201d responders with \u201cgood\u201d responders using a standard buserelin\/human menopausal gonadotrophin regime for in-vitro fertilization","volume":"6","author":"Jenkins","year":"1991","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2015.08.014_bib4","first-page":"CD004379","article-title":"Interventions for \u201cpoor responders\u201d to controlled ovarian hyperstimulation (COH) in in-vitro fertilisation (IVF)","author":"Shanbhag","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2015.08.014_bib5","first-page":"CD004379","article-title":"Interventions for \u201cpoor responders\u201d to controlled ovarian hyper stimulation (COH) in in-vitro fertilisation (IVF)","author":"Pandian","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2015.08.014_bib6","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.fertnstert.2007.12.077","article-title":"How to improve the probability of pregnancy in poor responders undergoing in\u00a0vitro fertilization: a systematic review and meta-analysis","volume":"91","author":"Kyrou","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.08.014_bib7","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0015-0282(99)00630-5","article-title":"Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques","volume":"73","author":"Surrey","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.08.014_bib8","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.fertnstert.2011.09.048","article-title":"A systematic review of randomized trials for the treatment of poor ovarian responders: is there any light at the end of the tunnel?","volume":"96","author":"Polyzos","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.08.014_bib9","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s10815-007-9180-3","article-title":"Management of the poor responder: the role of GnRH agonists and antagonists","volume":"24","author":"Surrey","year":"2007","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2015.08.014_bib10","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0015-0282(16)56700-4","article-title":"Enhancement of ovarian responsiveness with microdoses of gonadotropin-releasing hormone agonist during ovulation induction for in\u00a0vitro fertilization","volume":"61","author":"Scott","year":"1994","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.08.014_bib11","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0015-0282(97)00575-X","article-title":"Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in\u00a0vitro fertilization","volume":"69","author":"Surrey","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.08.014_bib12","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0015-0282(16)53285-3","article-title":"Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: a better alternative for ovulation induction in in\u00a0vitro fertilization","volume":"53","author":"Garcia","year":"1990","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.08.014_bib13","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S0015-0282(16)58216-8","article-title":"Use of the flare-up protocol with high dose human follicle stimulating hormone and human menopausal gonadotropins for in\u00a0vitro fertilization in poor responders","volume":"65","author":"Padilla","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.08.014_bib14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.fertnstert.2013.09.035","article-title":"Long gonadotropin-releasing hormone agonist versus short agonist versus antagonist regimens in poor responders undergoing in\u00a0vitro fertilization: a randomized controlled trial","volume":"101","author":"Sunkara","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.08.014_bib15","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.fertnstert.2009.03.027","article-title":"What is the optimum maximal gonadotropin dosage used in microdose flare-up cycles in poor responders?","volume":"94","author":"Berkkanoglu","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.08.014_bib16","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/humrep\/deh663","article-title":"Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial","volume":"20","author":"Klinkert","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2015.08.014_bib17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/oxfordjournals.humrep.a138053","article-title":"Doubling the human menopausal gonadotrophin dose in the course of an in-vitro fertilization treatment cycle in low responders: a randomized study","volume":"8","author":"van Hooff","year":"1993","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2015.08.014_bib18","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0015-0282(00)00471-4","article-title":"A comparative study of high fixed-dose and decremental-dose regimens of gonadotropins in a minidose gonadotropin-releasing hormone agonist flare protocol for poor responders","volume":"73","author":"Cedrin-Durnerin","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.08.014_bib19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/humupd\/dmg007","article-title":"Clinical management of low ovarian response to stimulation for IVF: a systematic review","volume":"9","author":"Tarlatzis","year":"2003","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2015.08.014_bib20","unstructured":"National Institute for Health and Care Excellence. Fertility: assessment and treatment for people with fertility problems. Available at: www.nice.org.uk\/guidance\/cg156. Last accessed November 3, 2015."},{"key":"10.1016\/j.fertnstert.2015.08.014_bib21","unstructured":"Leong M, Patrizio P. IVF worldwide survey. Poor responders: how to define, diagnose and treat? Available at: www.ivf-worldwide.com\/survey\/poor-responders\/results-poor-responders.html. Last accessed November 3, 2015."},{"key":"10.1016\/j.fertnstert.2015.08.014_bib22","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/S0015-0282(99)00334-9","article-title":"Prognostic factors in patients continuing in\u00a0vitro fertilization or intracytoplasmic sperm injection treatment and dropouts","volume":"72","author":"de Vries","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.08.014_bib23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0015-0282(02)03160-6","article-title":"Factors influencing the cumulative conception rate and discontinuation of in\u00a0vitro fertilization treatment for infertility","volume":"78","author":"Sharma","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.08.014_bib24","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1472-6483(10)62164-5","article-title":"Conception rates following assisted reproduction in poor responder patients: a retrospective study in 300 consecutive cycles","volume":"6","author":"Ulug","year":"2003","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2015.08.014_bib25","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1093\/humrep\/deu151","article-title":"Live birth rates after IVF are reduced by both low and high progesterone levels on the day of human chorionic gonadotrophin administration","volume":"29","author":"Santos-Ribeiro","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2015.08.014_bib26","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0015-0282(16)56874-5","article-title":"The value of increasing the dose of human menopausal gonadotropins in women who initially demonstrate a poor response","volume":"62","author":"Manzi","year":"1994","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.08.014_bib27","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3109\/09513590.2011.569784","article-title":"Does 75 IU difference improve the cycle performance in poor responders? Comparison of daily 375 versus 450 IU gonadotrophin doses","volume":"27","author":"Dilbaz","year":"2011","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2015.08.014_bib28","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1080\/01443610701327420","article-title":"What should be the maximum FSH dose in IVF\/ICSI in poor responders?","volume":"27","author":"Siristatidis","year":"2007","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2015.08.014_bib29","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0015-0282(98)00268-4","article-title":"Evaluation of the ovarian reserve in young low responders with normal basal levels of follicle-stimulating hormone using three-dimensional ultrasonography","volume":"70","author":"Pellicer","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.08.014_bib30","first-page":"163","article-title":"Purification of a high molecular weight follicle-stimulating hormone receptor-binding inhibitor from human follicular fluid","volume":"77","author":"Lee","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2015.08.014_bib31","doi-asserted-by":"crossref","first-page":"762541","DOI":"10.1155\/2012\/762541","article-title":"Review on autoimmune reactions in female infertility: antibodies to follicle stimulating hormone","volume":"2012","author":"Haller-Kikkatalo","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.fertnstert.2015.08.014_bib32","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/oxfordjournals.humrep.a138600","article-title":"Aetiological factors involved in the low response to gonadotrophins in infertile women with normal basal serum follicle stimulating hormone levels","volume":"9","author":"Pellicer","year":"1994","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2015.08.014_bib33","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1093\/humrep\/13.12.3425","article-title":"Perivitelline space granularity: a sign of human menopausal gonadotrophin overdose in intracytoplasmic sperm injection","volume":"13","author":"Hassan-Ali","year":"1998","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2015.08.014_bib34","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0015-0282(16)49632-9","article-title":"Differences in ovarian stimulation in human menopausal gonadotropin treated woman may be related to follicle-stimulating hormone accumulation","volume":"46","author":"Ben-Rafael","year":"1986","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.08.014_bib35","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1016\/j.fertnstert.2008.03.057","article-title":"Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection-embryo transfer cycle","volume":"91","author":"Kahraman","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.08.014_bib36","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1093\/humrep\/15.10.2145","article-title":"Addition of GnRH antagonist in cycles of poor responders undergoing IVF","volume":"15","author":"Akman","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2015.08.014_bib37","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1093\/humrep\/deh273","article-title":"Defining poor ovarian response during IVF cycles, in women aged <40 years, and its relationship with treatment outcome","volume":"19","author":"Kailasam","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2015.08.014_bib38","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/humupd\/dms041","article-title":"Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach","volume":"19","author":"Broer","year":"2013","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2015.08.014_bib39","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0015-0282(02)04839-2","article-title":"Women older than 40 years of age and those with elevated follicle-stimulating hormone levels differ in poor response rate and embryo quality in in\u00a0vitro fertilization","volume":"79","author":"van Rooij","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.08.014_bib40","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10815-013-9975-3","article-title":"Antral follicle count determines poor ovarian response better than anti-Mullerian hormone but age is the only predictor for live birth in in\u00a0vitro fertilization cycles","volume":"30","author":"Mutlu","year":"2013","journal-title":"J Assist Reprod Genet"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028215018518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028215018518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T01:00:06Z","timestamp":1666486806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028215018518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0015028215018518"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2015.08.014","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"450 IU versus 600 IU gonadotropin for controlled ovarian stimulation in poor responders: a randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2015.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}